• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
44.82
  0.62  
+ 1.40%
519,781,000
49.83
25.49

Insider Trade Data

Date Insider Shares Type Value
08/26/2014 Moy, Jeffrey C 16,663 Sell $754,835
08/26/2014 Moy, Jeffrey C 16,663 Exchange $140,177
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/26/2014 Pacelli, Steven Robert 30,000 Exchange $437,220

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!